2HXS
| |
2R0O
| |
2Q97
| |
3E5H
| Crystal Structure of Rab28 GTPase in the Active (GppNHp-bound) Form | 分子名称: | GLYCEROL, MAGNESIUM ION, PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER, ... | 著者 | Lee, S.H, Baek, K, Li, Y, Dominguez, R. | 登録日 | 2008-08-13 | 公開日 | 2008-08-26 | 最終更新日 | 2023-08-30 | 実験手法 | X-RAY DIFFRACTION (1.499 Å) | 主引用文献 | Large nucleotide-dependent conformational change in Rab28. Febs Lett., 582, 2008
|
|
2D1L
| Structure of F-actin binding domain IMD of MIM (Missing In Metastasis) | 分子名称: | Metastasis suppressor protein 1 | 著者 | Lee, S.H, Kerff, F, Chereau, D, Ferron, F, Dominguez, R. | 登録日 | 2005-08-27 | 公開日 | 2006-09-12 | 最終更新日 | 2017-10-11 | 実験手法 | X-RAY DIFFRACTION (1.85 Å) | 主引用文献 | Structural basis for the actin-binding function of missing-in-metastasis Structure, 15, 2007
|
|
6LRP
| |
6LRT
| |
8HKA
| |
8HK9
| |
8HKB
| |
8H5M
| |
8H5K
| |
8H5O
| |
8H5J
| |
8H5L
| |
7W1G
| Crystal structure of YfiH with C107A mutation in complex with UDP-MurNAc-L-Serine | 分子名称: | (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid, (2S)-2-[[(2R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-2-[[[(2R,3S,4R,5R)-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-6-(hydroxymethyl)-5-oxidanyl-oxan-4-yl]oxypropanoyl]amino]-3-oxidanyl-propanoic acid, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, ... | 著者 | Lee, S.H, Hsieh, K.Y, Lee, M.S, Chang, C.I. | 登録日 | 2021-11-19 | 公開日 | 2021-12-29 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (1.86 Å) | 主引用文献 | Structural Basis for the Peptidoglycan-Editing Activity of YfiH. Mbio, 13, 2021
|
|
7BXA
| Crystal structure of PD-1 in complex with tislelizumab Fab | 分子名称: | Programmed cell death protein 1, heavy chain, light chain | 著者 | Heo, Y.S, Lee, S.H, Lim, H, Lee, H.T, Kim, Y.J, Park, E.B. | 登録日 | 2020-04-18 | 公開日 | 2020-06-10 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (3.32 Å) | 主引用文献 | Crystal structure of PD-1 in complex with an antibody-drug tislelizumab used in tumor immune checkpoint therapy. Biochem.Biophys.Res.Commun., 527, 2020
|
|
8JCT
| |
4R1P
| |
5DBT
| |
5DBU
| |
6J4N
| Structure of papua new guinea MBL-1(PNGM-1) native | 分子名称: | Metallo-beta-lactamases PNGM-1, ZINC ION | 著者 | Hong, M.K, Park, K.S, Jeon, J.H, Lee, J.H, Park, Y.S, Lee, S.H, Kang, L.W. | 登録日 | 2019-01-10 | 公開日 | 2019-02-27 | 最終更新日 | 2024-03-27 | 実験手法 | X-RAY DIFFRACTION (2.1 Å) | 主引用文献 | The novel metallo-beta-lactamase PNGM-1 from a deep-sea sediment metagenome: crystallization and X-ray crystallographic analysis. Acta Crystallogr F Struct Biol Commun, 74, 2018
|
|
4YVM
| |
4ZRM
| |
4ZRN
| |